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Abstract
Background: Few studies have been conducted in Uganda to identify and quantify the determinants of HIV-1 infection. We
report results from a community-based cohort study, whose primary objectives were to determine HIV-1 prevalence,
incidence, and determinants of these infections, among other objectives.
Methodology: Consenting volunteers from the rural district of Kayunga in Uganda aged 15–49 years were enrolled between
March and July 2006. Participants were evaluated every six months. A questionnaire that collected information on behavioral
and other HIV-1 risk factors was administered, and a blood sample obtained for laboratory analysis at each study visit.
Principal Findings: HIV-1 prevalence among the 2025 participants was 9.9% (95% CI=8.6%–11.2%). By the end of
12 months of follow-up, 1689.7 person-years had been accumulated, with a median follow-up time of 11.97 months.
Thirteen HIV-1 incident cases were detected giving an annual HIV-1 incidence of 0.77% (95% CI=0.35–1.19). Prevalence of
HSV-2 infection was 57% and was strongly associated with prevalent HIV-1 infection (adjusted Odds Ratio=3.9, 95%
CI=2.50–6.17); as well as incident HIV-1 infection (adjusted Rate Ratio (RR)=8.7, 95% CI=1.11–67.2). The single most
important behavioral characteristic associated with incident HIV infection was the number of times in the past 6 months, a
participant had sex with person(s) they suspected/knew were having sex with others; attaining statistical significance at 10
times and higher (adjusted RR=6.3, 95% CI=1.73–23.1). By the end of 12 months of follow-up, 259 participants (13%) were
lost to follow-up, 13 (0.6%) had died, and 2 (0.1%) had withdrawn consent.
Conclusions: Despite relatively low HIV-1 incidence observed in this community, prevalence remains relatively high. In the
presence of high prevalence of HSV-2 infection and the behavioral characteristic of having sex with more than one partner,
there is potential for increase in HIV-1 incidence.
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Introduction
Accurate estimates of HIV-1 infection rates (prevalence and
incidence), and identification of associated risk factors in a
population is important for determining appropriate interventions.
Few community-based studies have been conducted in Uganda to
assess HIV-1 infection rates and determinants of these infections.
Previously reported HIV-1 prevalence and incident estimates have
primarily been based on sentinel surveillance data at antenatal
clinics. Although some validation studies have shown that HIV-1
trends among women attending antenatal clinics provide a fairly
accurate reflection of trends in HIV-1 infection among females in
the general population, it may not correctly reflect the overall
HIV-1 infection rates in the general population as HIV-1 infection
tends to be generally higher among females compared to males
[1]. Other validation studies have shown that HIV-1 surveillance
based on antenatal clinic data overestimate trends in HIV-1
infection in some age-groups in the general population, whereas in
other age-groups it underestimates [2]. Community-based studies
therefore provide more accurate estimates of HIV-1 infection rates
in the general population.
The few community-based studies that have assessed the
distribution and determinants HIV-1 infection in Uganda have
mostly been from cohort studies conducted in the south western
Ugandan districts of Rakai and Masaka [3–6]. Nationally, there
have only been two national surveys conducted by Uganda’s
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most recent conducted in 2005 [7]. An attempt was made to
estimate incidence by subjecting all HIV-1 positive samples
collected in the most recent survey to the BED-assay [8].
However, there is evidence suggesting that this test overestimates
incidence [9]. Therefore, the distribution and determinants of
HIV-1 infection rates in other parts of Uganda, other than the
districts of Rakai and Masaka, have not been examined.
In this article the authors report results from a community-
based closed cohort study, which is part of preparatory research
for Phase III HIV vaccine efficacy trials being conducted by the
Makerere University-Walter Reed Project in Uganda, a project
sponsored by the US Military HIV Vaccine Research Program
network. The study was conducted in Kayunga District, a rural
district located in the mid-central part of Uganda, with an
estimated population of 320,000 [10]. The district has nine Sub-
Counties, and six of these were randomly selected as the study
area. The estimated population of individuals aged 15–49 years in
the six sub-counties is 111,394 people [10]. The main objectives of
the study were to determine HIV-1 prevalence, incidence and risk
factors associated with HIV-1 infection, to identify HIV-1 viral
subtypes circulating in this part of Uganda, and determine cohort
participant retention and willingness to participate in future HIV
vaccine efficacy trials.
Methods
Ethics Statement
The Institutional Review Boards of Uganda’s National Council
for Science and Technology (UNCST), that is, the National AIDS
Research Committee (NARC); and that of the Walter Reed Army
Institute of Research (WRAIR), approved the conduct of this
study, including approval of the written informed consent form
used in this study.
Recruitment
Recruitment for participants was conducted using two approach-
es; the ‘‘house-to-house’’ recruitment strategy, and the ‘‘broadcast’’
recruitment strategy. The house-to-house recruitment strategy
involved trained Community Mobilizers (CMs) moving from
house-to-house providing information about the study to household
members. The CMs further invited household members to
information seminars that were organized by the research team at
strategic locations within the community. At the end of each
information seminar, individuals aged 15–49 years wereencouraged
to report to a designated health center within their community, at
which the research team provided more details about participation
in the cohort study. One health center within each of the six study
sub-counties was selected to serve as the study site for enrolling and
follow-up evaluations of participants.
The ‘‘broadcast’’ recruitment strategy involved use of IRB-
approved banners, fliers, posters and public announcements in the
urban section of Kayunga town, the main town of the district. The
messages invited potential volunteers to the health center nearest
to Kayunga town to be provided more details about participation
in the study.
Enrollment and study procedures
At the designated health centers, the study was explained further
in a one-on-one session with a study counselor and a written
informed consent obtained. Residents of the six study sub-counties
aged 15 to 49 years, willing to provide a blood sample and able to
give consent (plus assent for volunteers aged 15 to 17 years) were
enrolled. Contact information was then obtained, a blood sample
collected, and a questionnaire administered. The questionnaire
collected information on basic social demographics, general health,
knowledge about vaccines, willingness to participate in a future
preventive HIV-1 vaccine efficacy trials, HIV/AIDS knowledge,
and behavioral risk factors for HIV-1. Data collected on behavioral
risk factors for HIV included; type and number of sexual partners in
past 6 months, frequency of having sex with such partners,
frequency of condom use, having sex after taking alcohol, paying
or being paid for sex, etc. Participants also provided a medical
history and received a physical examination that included
observations for weight, temperature, blood pressure, pulse and
presence of lymphadenopathy. A blood sample was then obtained
for HIV-1 testing and other laboratory study tests. Participants were
evaluated every six months and at each study visit trained
interviewers administered a standardized questionnaire.
HIV testing was performed on all participants, and at each
study visit. Testing was performed using previously described
ELISA and western blot methods [11]. Samples found to be
indeternminate or reactive in the Western Blot were subjected to
the Amplicor HIV-1 Monitor test, version 1.5 (Roche Dignostics,
Indianapolis, Ind.) in the standard mode. The algorithm for HIV-
1 testing and sero-status classification is summarized in Figure 1.
All identified HIV-1 sero-positive participants’ plasma samples
were tested for virus subtype using previously described multi-
region hybridization assay (MHA), version 2, for HIV-1 subtypes
A, C, D, recombinants, and dual infections [3,12,13].
HIV pre-test and post-test counseling sessions were conducted
in a private room with great attention paid to the preservation of
participant confidentiality. Participants returned to receive their
blood test results two weeks after the blood draw. Consistent with
Ugandan guidelines, test results including HIV results were
provided to participants only if they were ready to receive their
results. In case a participant was not ready to receive their results,
continued post test counseling would be provided at subsequent
study visits. Identified HIV sero-positive participants were referred
to Kayunga District Hospital where they would receive compre-
hensive HIV care and treatment.
Screening for Hepatitis B surface antigen (HBsAg) was performed
using the Genetic Systems HBsAg EIA 3.0 (BioRad Laboratories,
Redmond, WA). Repeatedly reactive samples were confirmed using
the Genetic Systems Confirmatory Assay 3.0 (BioRad Laboratories,
Redmond, WA). Screening for anti-Hepatitis C antibody was
performed using the Ortho HCV Version 3.0 ELISA Tests System.
Repeatedly reactive samples were tested in the Chiron RIBA HCV
3.0SIA(ChironCorporation,Emeryville, CA).Syphilisserologywas
conducted using the Wampole Impact Rapid Plasma Reagin (RPR)
kit (Inverness Medical Professional Diagnostics, Princeton, NJ) and
confirmed using a Serodia Treponema pallidum particle agglutina-
tion (TP-PA) test (Fujirebio, Tokyo, Japan). All samples were tested
for the Herpes Simplex Virus Type 2 (HSV-2) antibody with an
ELISA kit from Focus Diagnostics (Focus Technologies, Cypres,
Calif.). A higher sample index value cutoff of 3.4 was used to
opyimize the performance of the assay as previously described [14].
Participant Follow-up and Retention Strategies
In order to minimize loss to follow-up, CMs maintained contact
with study participants by making a visit to their home mid-way
between, and one week before the scheduled 6–monthly visit
reminding each participant of their scheduled follow-up visit. Further,
if a study participant purportedly away from their place of residence
in between their study visits, attempts were made to trace them to
their new locations using the provided contact information.
Participants were treated for acute febrile infections and minor
ailments free of charge at any time during the study period. In case
HIV Infection Rates in Uganda
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as outpatient care, participants were referred to Kayunga District
Hospital where they could be hospitalized during treatment and
care.
Statistical Analysis
HIV-1 prevalencewas calculated as the percentage of participants
enrolled intothe study,whotestedHIV-1positiveatbaseline.HIV-1
incidence rates were calculated using person-time analysis, with the
numerator being the number of participants who sero-converted
during follow-up, the denominator being the cumulative number of
person-years contributed by the HIV-1 sero-negative participants,
from baseline onwards during follow-up. HIV-1 sero-negative
individuals contributed person-time to the denominator beginning
from baseline until the time of sero-conversion or until conclusion of
the study or when censored. For HIV-1 sero-converters, the date of
sero-conversion was calculated as the mid-time point between the
visit date of the last HIV-1 sero-negative test and first HIV-1 sero-
positive test. All HIV-1 sero-converters contributed zeroperson-time
from their calculated date of sero-conversion onwards.
Logistic regression analysis was used to identify factors associated
with prevalent HIV-1 infection. Odds ratios (OR) with their
corresponding 95% confidence intervals (95% CI) are reported.
Poisson regression analysis was used to identify factors associated
new HIV infections by comparing incidence rates of HIV-1
infection between participants with the baseline factor of interest
and those without. Incidence rate ratios (RR) with their
corresponding 95% CI are reported. All risk factors variables for
HIV infection measured in this study were examined for possible
association with prevalent, and/or incident HIV-1 infection.
Except for a few selected variables, only variables found to be
significantly associated with prevalent or incident HIV-1 infection
are presented. All statistical analyses were performed using the
Statistical Analysis Software Version 8.2 [15].
Results
Characteristics of cohort participants
A total of 2025 participants, representing 1.8% of community
members aged 15–49 years within the study area were enrolled, of
which 945 (47%) were males. The average age of the participants
was 28.5 (standard deviation=8.1) years. Male participants were
on average younger with an average age of 27.3 (68.0), compared
to females with an average age of 28.6 (68.2), p-value=0.004. The
education level of participants was low as the majority had at most
completed primary school level (53.0%). The main occupation of
Figure 1. Algorithm for HIV testing.
doi:10.1371/journal.pone.0004145.g001
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baseline demographic and social characteristics of the participants.
Prevalence of HIV infection
A total of 201 participants tested HIV-1 sero-positive at baseline,
giving an overall prevalence of 9.9% (95% CI=8.6%–11.2%), with
significantly higher prevalence among females, 12.5% versus 7%
among males (p-value,0.001). Across the different age groups, HIV-
1 prevalence was lowest among participants aged 15–24 years
(5.8%) and highest among participants aged 40–44 years (17.7%).
On average HIV-1 prevalence increased with age with an overall
adjusted OR of 1.1 (95% CI=1.04–1.08) per year.
A total of 1155 (57%) tested positive for HSV-2 infection, with
significantly higher prevalence among females, 66.3% versus 46.5%
among males (p-value,0.001). HSV2 infection was significantly
associated with prevalent HIV-1 infections with an adjusted OR of
3.9, 95% CI=2.50–6.17. Of the 223 participants who tested
positive for syphilis infection, 44 (19.7%) were more likely to test
HIV-1 sero-positive compared to those testing negative for syphilis
157 (8.7%), with an adjusted OR=2.1 [1.42–3.16]. Participants
reporting to ever have had a traditional skin cutting on their body
were more likely to test HIV positive with a prevalence of 14.6%
versus those without a traditional skin cutting 6.9% (p-value,0.001),
with an adjusted OR=1.7 (95% CI=1.28–2.40). Among male
participants who reported to have ever had sex, HIV prevalence
was 5.7% among the circumcised versus 8.4% among the un-
circumcised, but this difference was not statistically significant,
adjustedOR 0.6(95%CI=0.34–1.16).Amongthe491 participants
reporting to have had sex with a casual partner in the past
6 months, frequency of condom use was not significantly associated
with prevalent HIV-1 infection (p-value=0.984).
Of the 513 participants reporting to have had sex in the past
6 months with persons they suspected/knew to be having sex with
other people, 240 (46.8%) never used a condom, 67 (13.1%) used a
condom a few times, 52 (10.1%) used a condom half of the time, 37
(7.2%)used acondommostofthetime,and117(22.8%)alwaysused
a condom. Condom use in this group was also not significantly
associated with prevalent HIV-1 infection (p-value=0.806). Table 2
summarizes the distribution of HIV prevalence, and multi-variable
analysis results of selected baseline characteristics.
Incidence of HIV Infection
By the end of 12 months of follow-up, a total of 1689.7 person-
years had been accumulated among the 1824 HIV-1 sero-negative
participants, with a median follow-up time of 11.97 months (Inter-
Quartile Range of 11.96 to 11.97 months). Thirthteen participants
sero-converted during follow-up, giving an estimated incidence of
0.77 per 100 person-years, (95% CI=0.35–1.19). HSV-2 infection
at baseline was strongly associated with HIV-1 incidence with an
adjusted RR of 8.7 (95% CI=1.11–67.2). Additionally, partici-
pants reporting to have had sex in the past 6 months with a
partner(s) they knew or suspected of having sex with others was
strongly associated with HIV-1 incidence. This risk increased with
the number of coital acts in the past 6 months, attaining statistical
significance at 10 times or more with an adjusted RR of 6.3 (95%
CI=1.73–23.1).
Annual HIV-1 incidence was highest in the age group 25–
29 years (1.68%), followed by the 35–39 years age group (1.05%).
However the differences between age groups were not statistically
significant (see Table 3). Of the 13 HIV-1incident cases, 9 were
females with an estimated annual incidence of 1.02%, compared
to 4 cases among males with an estimated annual incidence of
0.49%. The difference between male and female participants did
not attain statistical significance (adjusted RR=1.5, 95%
CI=0.41–5.14). A significantly higher incidence of HIV-1
infection was observed among participants residing in one of the
sub-counties with large fishing communities (Bbaale sub-County),
compared to any of the other five study sub-counties. Table 3
summarizes the incidence rate information.
By the end of 12 months of follow-up, 13 participants (0.6%)
were known to have died, 2 (0.1%) had withdrawn consent from
continuing participation in the study, 259 (13%) had been lost to
follow-up, while the remaining 1751 were still in active follow-up.
Table 1. Baseline demographic and social characteristics of
participants.
Characteristic Category - n-
Summary
measure
All participants - 2025 -
Sex: Males 945 46.7%
Females 1080 53.3%
Age (yrs): 15–19 283 14.0%
20–24 451 22.3%
25–29 354 17.5%
30–34 370 18.3%
35–39 344 17.0%
40–44 158 7.8%
45–49 65 3.2%
Mean6SD - 28.568.1
Employment category: Farmer 1000 49.4%
Student 288 14.2%
Trader 164 8.1%
Unemployed 101 5.0%
Civil servant/NGO
employee
63 3.1%
Housewife 48 2.4%
Bar/Restaurant worker 16 0.8%
Others 345 17.0%
Education level completed: None 148 7.3%
Primary unfinished 652 32.2%
Primary finished 274 13.5%
O’level unfinished 580 28.6%
O’level finished 183 9.0%
Higher than O’level 188 9.3%
Marital status: Single 574 28.3%
Married to 1 spouse 1091 53.9%
Married to more than 1
spouse
62 3.1%
Cohabiting 32 1.6%
Separated/Divorced 254 12.5%
Widowed 12 0.6%
Sub-county of residence: Kayunga Town 281 46.0%
Kayunga 931 13.9%
Kayonza 262 12.9%
Kangulumira 257 12.7%
Nazigo 229 11.3%
Bbaale 65 3.2%
doi:10.1371/journal.pone.0004145.t001
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86%. Loss to follow-up was highest in the age groups less than
25 years with an average of 21.4%, compared to those aged
25 years or older with an average of 7.9% (p-value,0.001).
Other Results
MHA analysis was performed on 105 of the 201 participants
testing HIV-1 positive at baseline. The predominant HIV-1
subtype was clade A (45%), followed by clade D (23%), and clade
C (1%). The rest were recombinant HIV-1 sub-types (23%), or
dually reactive (8%). Prevalence of Hepatitis B surface antigen was
4.6%, for Hepatitis C antibody it was 0.6%, and for Syphilis it was
11.0%.
Discussion
Results from this study show a relatively high HIV-1 prevalence
of 9.9% in this rural Ugandan community, compared to the
national average of 6.4% [7]. But the annual HIV-1 incidence of
0.77% is lower than what has been reported from similar rural
Ugandan communities of Rakai and Masaka districts that has
ranged between 1.03 to 1.50% per year [3,16–19]. A number of
studies have shown a decline in Ugandan HIV-1 infection rates
[7,20–22]. For Kayunga District, until 2005 there had been few
HIV-1 interventions compared to other parts of Uganda that have
benefited from intensified HIV-1 prevention programs for longer
periods of time, which may explain the relatively higher HIV-1
prevalence in this community. Conversely, the relatively low HIV-
1 incidence gives optimism that the burden of HIV-1 infection will
decline in the near future, if the current HIV-1 prevention
interventions are continued.
Our study also shows that the burden of HIV-1 infection is
concentrated in the age groups above 30 years. This distribution is
consistent with findings from other studies showing a shift in the
burden of HIV-1 infection from young adults aged 20–25 years
old, as previously described in the late 1980s and early 1990s
[23,24]; to older adults aged 30–40 years [7]. This shift in burden
has been attributed to HIV-1 risk reduction among young adults
[25]. The relatively low HIV-1 prevalence among young adults
compared to older adults seem to suggest that most of the
Table 2. Prevalence of HIV infection, by baseline characteristics of participants.
Characteristic Category - n- # HIV +ve (%) Adjusted OR 95% CI p-value
All participants - 2025 201 (9.9) - - -
Sex: Males 945 66 (7.0) 1.0 -
Females 1080 135 (12.5) 1.0 0.72–1.43 0.933
Age (yrs): 15–24 734 27 (5.8) 1.0 - -
25–29 354 34 (9.6) 1.5 0.87–2.57 0.734
30–34 370 55 (14.9) 2.2 1.34–3.63 0.006
35–39 344 49 (14.2) 1.7 1.04–2.91 0.207
40–44 158 28 (17.7) 1.9 1.03–3.39 0.167
45–49 65 6 (9.2) 0.7 0.27–1.92 0.082
Marital status: Single or Married 1726 124 (9.4) 1.0 -
Cohabiting 32 8 (25.0) 4.1 1.74–9.78 0.075
Separated/Divorced 267 69 (25.8) 3.6 2.53–5.11 0.032
Circumcision status of males who have ever had sex
(n=850):
No 536 45 (8.4) 1.0 - -
Yes 314 18 (5.7) 0.6 0.34–1.16 0.137
Ever had a traditional skin cutting on body?: No 1246 86 (6.9) 1.0 -
Yes 779 114 (14.6) 1.7 1.28–2.40 ,0.001
HSV2 infection: No 870 25 (2.9) 1.0 -
Yes 1155 176 (15.2) 3.9 2.50–6.17 ,0.001
Syphilis infection: No 1802 157 (8.7) 1.0 -
Yes 223 44 (19.7) 2.1 1.42–3.16 ,0.001
Frequency of condom use among participants who had
sex with a casual partner in past 6 months (n=419)
Every time 52 16 (7.3) 1.0
Never 55 13 (10.9) 0.9 0.38–2.12 0.347
A few times 46 6 (11.5) 0.9 0.29–2.64 0.522
Half of the time 10 (18.2) 0.2 0.09–1.64 0.080
Most times 3 (6.5) 0.7 0.17–2.61 0.984
# of times in past 6 months had sex with someone
thought to be having sex with others:
None 1520 154 (10.1) 1.0
1–2 times 171 13 (7.6)
3–10 times 178 13 (7.3) 0.5 0.26–0.89 0.097
.10 times 156 21 (13.5) 1.1 0.62–1.79 0.085
doi:10.1371/journal.pone.0004145.t002
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in the remote past, suggesting a possible cohort effect.
Six of the 13 HIV-1 incident cases occurred among participants
reporting to be marriedto one spouse.A closerexamination of these
incident cases revealed that 4 of them reported at baseline to have
had sex at least 3 times in the past six months, with a partner they
knew or suspected of having sex with others. Some investigators
have asserted that a substantial number of new HIV-1 infections in
Uganda are now occurring among married individuals engaging in
risky sexual behavior outside of their marital relationships [26,27].
Indeed the single most important behavioral characteristic
identified in our study as fueling the spread of HIV-1 infection in
this community was having sex with partners known or suspected of
having sex with others. Furthermore, there was a clear dose
response of this behavior with the increasing number of times one
had sex with such partners in the past 6 months. Therefore the
message of ‘‘being faithful’’ to one’s HIV-1 uninfected faithful
sexual partner(s) must be emphasized in this community as part of
the HIV-1 risk reduction package.
Our study also shows a high prevalence of HSV-2 infection in this
rural community that was strongly associated with prevalent, as well
as incident HIV-1 infections. HSV-2 infection has been identified as
the most common cause of genital ulcerative disease worldwide
[28,29]. The major public health importance of HSV-2 relates to its
potential role in facilitating HIV transmission [29,30]. Genital
ulcerative disease enhances the infectiousness of HIV-1 positive
subjects and the susceptibility of HIV-1 uninfected subject’s
susceptibility to HIV-1 infection. Accumulating data suggest that
HSV-2 may be responsible for a substantial proportion of new HIV-
1 infections in many parts of Africa [31–33]. There is therefore an
urgent need to provide health education about HSV-2 infection and
its potential role in enhancing HIV-1 transmission.
The predominant HIV-1 sub-types identified in this study was
clade A (45%), followed by clade D (23%). The distribution of
HIV-1 subtypes found in this community is slightly different from
that found in another Ugandan rural district of Rakai, located in
the southern western part of the country, where clade D was the
most predominant (54%), followed by clade A (15%) [34]. The
distribution in our study is however similar to that found in a
number of studies conducted in neighboring Kenya where clade A
has been found to be predominant (greater than 50% in all
studies), followed by clade D [35,36].
One of the possible limitations in this analysis is that the follow-
up period may not have been long enough to accumulate enough
Table 3. Association between selected baseline factors to incident HIV infections.
Baseline Characteristic Category
New cases/
person-yrs
Incidence/per
100 person-yrs Adjusted RR 95% CI p-value
All participants 13/1689.7 0.77 - - -
Sex: Males 4/809.8 0.49 1.0
Females 9/880.0 1.02 1.46 0.41–5.14 0.556
Age (yrs): 15–19 0/251.9 - -
20–24 2/372.2 0.54 1.0
25–29 5/297.9 1.68 1.41 0.26–7.53 0.689
30–34 3/302.5 0.99 0.67 0.11–4.15 0.667
35–39 3/282.4 1.06 0.58 0.09–3.68 0.568
40–44 0/126.1 - -
45–49 0/56.9 - -
Sub-county of residence: Kayunga Town 2/748.6 0.27 1.0
Bbaale 3/50.6 5.93 25.7 4.18–158.1 ,0.001
Kangulumira 2/226.0 0.88 3.56 0.50–25.4 0.205
Kayonza 1/237.6 0.42 1.10 0.10–12.2 0.935
Kayunga 3/227.2 1.32 4.50 0.75–27.1 0.100
Nazigo 2/199.6 1.00 4.27 0.60–30.4 0.147
Marital status: Never married 3/493.8 0.61 1.0 -
Married, 1 spouse 6/942.9 0.64 0.18 0.04–0.87 0.033
Married, .1 spouse 0/53.1 - - -
Cohabiting 0/21.3 - - -
Separated/Divorced 4/171.0 2.34 2.12 0.37–12.2 0.838
Widowed 0/79.5 - - -
# of times in past 6 months had sex with someone
thought to be having sex with others:
None 6/1094.0 0.55 1.0
1–2 times 1/148.0 0.68 0.83 0.10–7.01 0.863
3–10 times 2/152.8 1.31 2.11 0.42–10.5 0.361
.10 times 4/128.9 3.10 6.33 1.73–23.1 0.005
HSV2 infection: No 1/771.8 0.13 1.0
Yes 12/908.9 1.32 8.65 1.11–67.2 0.039
doi:10.1371/journal.pone.0004145.t003
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infections in this community. The median follow-up time was only
11.89 months. Secondly, it is possible that the HIV-1 risk level of
individuals who volunteered to participate in this study is quite
different from other community members who did participate in
this study, thus creating a selection bias in our study. It is difficult
to tell the possible direction of this bias, but we believe that
findings from this study do not differ significantly from the truth,
and therefore provide useful information.
We conclude that although HIV-1 prevalence in this commu-
nity is still relatively high, incidence is relatively low. The low
incidence gives optimism that behaviors are changing and this will
lead to further reductions in the HIV-1 infection rates. However,
the high prevalence of HIV-1 infection, in presence of high
prevalence of HSV-2 infection, and the behavior of concurrently
having sex with multiple partners are suitable conditions for a rise
in HIV-1 infection rates in the near future. Behavioral change has
been identified as one of the most important factors that has
significantly contributed to the decline in HIV-1 infection rates in
Uganda, especially sexual partner reduction [20,21,37]. Behav-
ioral HIV-1 risk reduction interventions should be intensified to
enable further reductions in HIV-1 infection rates in this
community. Health education about HSV-2 infection should be
intensified, especially regarding its potential role in enhancing
HIV-1 transmission.
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